Cicor Technologies Ltd

  • ISIN: CH0008702190
  • Land: Schweiz

Nachricht vom 21.06.2021 | 07:01

Successful renewal and increase of syndicated loan provides financing and liquidity security and offers room for future acquisitions

Cicor Technologies Ltd / Key word(s): AGMEGM

21-Jun-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Successful renegotiation of syndicated loan

Cicor is replacing the existing syndicated loan of CHF 75 million due on June 30, 2022 early and at attractive conditions and is increasing it to CHF 80 million.

The new syndicated loan has a term of four years with two one-year extension options. The renewal of the revolving credit facility provides financing and liquidity security and increases Cicor's overall strategic flexibility.

The syndicated loan was structured as a club deal. The banking syndicate comprises a core banking group consisting of Commerzbank AG as mandated arranger and agent, HSBC Trinkaus & Burkhardt AG, Landesbank Baden-Württemberg, Migros Bank AG and Zürcher Kantonalbank.

Additional optional acquisition credit facility

The new credit agreement also contains an optional acquisition credit line in the amount of CHF 75 million, which, in the event of a future acquisition, is to be used to finance the purchase price and the working capital of the company to be acquired.

Alexander Hagemann
CEO
Tel. +41 71 913 73 00
E-mail: media@cicor.com

Patric Schoch
CFO
Tel. +41 71 913 73 00
E-mail: media@cicor.com

Ad hoc announcement in pursuance of Art. 53 LR

Bronschhofen, June 21, 2021 - Cicor (SIX Swiss Exchange: CICN), a leading international technology company in the fields of printed circuit boards and hybrid circuits, printed electronics, microelectronics as well as EMS (Electronic Manufacturing Services), based in Boudry (Switzerland) signed a credit agreement on 18 June 2021 for a new revolving credit facility of CHF 80 million and for an additional optional acquisition credit facility of CHF 75 million.

Cicor Management AG
Gebenloostrasse 15
9552 Bronschhofen
Switzerland

The Cicor Group is a globally active development and manufacturing partner with innovative technology solutions for the electronics industry. With about 1900 employees at ten production sites, Cicor offers highly complex printed circuit boards, hybrid circuits and printed electronics as well as comprehensive electronic manufacturing services (EMS) including microelectronic assembly and plastic injection molding. Cicor sup-plies customized products and services from design to the finished product from one source. The shares of Cicor Technologies Ltd. are listed on the SIX Swiss Exchange (CICN). For further information please visit the website www.cicor.com.



End of ad hoc announcement

show this

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“

GBC-Fokusbox

Kaufen: Aspermont Limited hat Turnaround abgeschlossen

Aspermont Limited ist der weltweit führende Anbieter von Business-to-Business-Medien (B2B) für den Rohstoffsektor. Mit einem neuen Management hat das Unternehmen seit 2016 den erfolgreichen Turnaround von einem traditionellen Medienunternehmen zu einem digitalen B2B-XaaS-Geschäftsmodell umgesetzt. Das Unternehmen hat diesen Turnaround im GJ 2020 abgeschlossen, als es sein erstes positives EBITDA-Ergebnis verzeichnete. Auf der Grundlage unseres DCF-Modells haben wir ein Kursziel von 0,09 AUD (0,06 Euro) pro Aktie ermittelt und vergeben das Rating KAUFEN.

News im Fokus

Vonovia SE: Vonovia verkauft Berliner Wohnungsbestände aus dem Zukunfts- und Sozialpakt Wohnen

17. September 2021, 12:40

Aktueller Webcast

Stealth BioTherapeutics

Cantor Global Healthcare Conference Fireside Chat

30. September 2021

Aktuelle Research-Studie

CR Capital AG

Original-Research: CR Capital AG (von First Berlin Equity Research GmbH): Buy

17. September 2021